Olympus Turnaround Focused on Medical Devices

28 days ago

Rob Hale

"We started with one investment in Olympus. Olympus was perceived as a multiDindustry holding company... they had a camera business that was well known, but what was left was an incredible medical device franchise in GI endoscopes. We thought that they could build a strategy around that business and we were able to sync up with a management team that saw the same opportunity."

ValueAct identified Olympus as a candidate for strategic refocus. With its fading consumer camera business due to smartphone competition, the firm's strong medical device segment (particularly GI endoscopes) presents a clear turnaround catalyst. The commentary underscores the firm7s emphasis on operational focus as a key to unlocking value.

Related Stocks